HR 1613 · 118th Congress · Health
Drug Price Transparency in Medicaid Act of 2023
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health.(2023-03-24)
Plain Language Summary
[AI summary unavailable — showing source text]
Drug Price Transparency in Medicaid Act of 2023 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (20)
8 Democrats12 Republicans